These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
546 related articles for article (PubMed ID: 9040193)
1. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Drewitz DJ; Sampliner RE; Garewal HS Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193 [TBL] [Abstract][Full Text] [Related]
2. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up. Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182 [TBL] [Abstract][Full Text] [Related]
3. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. O'Connor JB; Falk GW; Richter JE Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525 [TBL] [Abstract][Full Text] [Related]
4. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761 [TBL] [Abstract][Full Text] [Related]
5. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768 [TBL] [Abstract][Full Text] [Related]
6. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort. Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018 [TBL] [Abstract][Full Text] [Related]
7. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444 [TBL] [Abstract][Full Text] [Related]
8. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]
9. Low incidence of adenocarcinoma and high-grade intraepithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study. Martinek J; Benes M; Brandtl P; Hucl T; Vasicek M; Voska L; Lanska V; Nosek V; Spicak J Endoscopy; 2008 Sep; 40(9):711-6. PubMed ID: 18698534 [TBL] [Abstract][Full Text] [Related]
10. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years]. Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842 [TBL] [Abstract][Full Text] [Related]
11. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Provenzale D; Schmitt C; Wong JB Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526 [TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740 [TBL] [Abstract][Full Text] [Related]
14. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Achkar E; Carey W Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739 [TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus and risk of esophageal adenocarcinoma. Cossentino MJ; Wong RK Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412 [TBL] [Abstract][Full Text] [Related]
16. Incidence of adenocarcinoma among patients with Barrett's esophagus. Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385 [TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of Barrett's high-grade dysplasia. Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and patient satisfaction with nurse-directed treatment of Barrett's esophagus. Schoenfeld P; Johnston M; Piorkowski M; Jones DM; Eloubeidi M; Provenzale D Am J Gastroenterol; 1998 Jun; 93(6):906-10. PubMed ID: 9647016 [TBL] [Abstract][Full Text] [Related]
20. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance]. Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]